Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies

Abdusaid Saidahmatov,Jianan Li,Shihao Xu,Xiaobei Hu,Xiangqian Gao,Weijuan Kan,Lixin Gao,Cong Li,Yuqiang Shi,Li Sheng,Peipei Wang,Yubo Zhou,Xuewu Liang,Jia Li,Hong Liu

DOI: https://doi.org/10.1021/acs.jmedchem.4c00837

IF: 8.039

2024-08-26

Journal of Medicinal Chemistry

Abstract:Co-inhibition of histone deacetylase (HDAC) and cyclin-dependent kinase (CDK) synergizes to produce enhanced antitumor effects and potentially overcomes the drug resistance. In this work, we discovered a series of novel CDK9/HDACs dual inhibitors. Among them, compound 8e was identified to show potent CDK9 and HDAC1 inhibitory activities, with IC(50) values at 88.4 and 168.9 nM, respectively, and exhibited antiproliferative capacities against hematological and solid tumor cells. Meanwhile, 8e...

chemistry, medicinal